vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and SI-BONE, Inc. (SIBN). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($76.4M vs $56.3M, roughly 1.4× SI-BONE, Inc.). SI-BONE, Inc. runs the higher net margin — -2.9% vs -39.1%, a 36.2% gap on every dollar of revenue. On growth, SI-BONE, Inc. posted the faster year-over-year revenue change (15.0% vs 11.9%). SI-BONE, Inc. produced more free cash flow last quarter ($440.0K vs $-12.2M). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs 22.0%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Bone Clones, Inc. manufactures, distributes, and sells osteological reproductions of human and animal bones. Located in Chatsworth, California, Bone Clones provides these reproductions to museums, universities, medical schools, and other educational institutions.

PRCT vs SIBN — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$76.4M
$56.3M
SIBN
Growing faster (revenue YoY)
SIBN
SIBN
+3.1% gap
SIBN
15.0%
11.9%
PRCT
Higher net margin
SIBN
SIBN
36.2% more per $
SIBN
-2.9%
-39.1%
PRCT
More free cash flow
SIBN
SIBN
$12.6M more FCF
SIBN
$440.0K
$-12.2M
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
31.0%
22.0%
SIBN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PRCT
PRCT
SIBN
SIBN
Revenue
$76.4M
$56.3M
Net Profit
$-29.8M
$-1.6M
Gross Margin
60.6%
79.0%
Operating Margin
-40.6%
-4.4%
Net Margin
-39.1%
-2.9%
Revenue YoY
11.9%
15.0%
Net Profit YoY
-58.3%
63.4%
EPS (diluted)
$-0.54
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SIBN
SIBN
Q4 25
$76.4M
$56.3M
Q3 25
$83.3M
$48.7M
Q2 25
$79.2M
$48.6M
Q1 25
$69.2M
$47.3M
Q4 24
$68.2M
$49.0M
Q3 24
$58.4M
$40.3M
Q2 24
$53.4M
$40.0M
Q1 24
$44.5M
$37.9M
Net Profit
PRCT
PRCT
SIBN
SIBN
Q4 25
$-29.8M
$-1.6M
Q3 25
$-21.4M
$-4.6M
Q2 25
$-19.6M
$-6.2M
Q1 25
$-24.7M
$-6.5M
Q4 24
$-18.9M
$-4.5M
Q3 24
$-21.0M
$-6.6M
Q2 24
$-25.6M
$-8.9M
Q1 24
$-26.0M
$-10.9M
Gross Margin
PRCT
PRCT
SIBN
SIBN
Q4 25
60.6%
79.0%
Q3 25
64.8%
79.8%
Q2 25
65.4%
79.8%
Q1 25
63.9%
79.7%
Q4 24
64.0%
79.1%
Q3 24
63.2%
79.1%
Q2 24
59.0%
79.0%
Q1 24
56.2%
78.9%
Operating Margin
PRCT
PRCT
SIBN
SIBN
Q4 25
-40.6%
-4.4%
Q3 25
-27.8%
-11.1%
Q2 25
-28.0%
-14.4%
Q1 25
-39.7%
-15.8%
Q4 24
-28.9%
-11.2%
Q3 24
-38.4%
-18.9%
Q2 24
-50.3%
-25.2%
Q1 24
-62.1%
-31.8%
Net Margin
PRCT
PRCT
SIBN
SIBN
Q4 25
-39.1%
-2.9%
Q3 25
-25.7%
-9.4%
Q2 25
-24.7%
-12.7%
Q1 25
-35.8%
-13.8%
Q4 24
-27.6%
-9.2%
Q3 24
-35.9%
-16.3%
Q2 24
-48.0%
-22.4%
Q1 24
-58.3%
-28.8%
EPS (diluted)
PRCT
PRCT
SIBN
SIBN
Q4 25
$-0.54
$-0.04
Q3 25
$-0.38
$-0.11
Q2 25
$-0.35
$-0.14
Q1 25
$-0.45
$-0.15
Q4 24
$-0.34
$-0.10
Q3 24
$-0.40
$-0.16
Q2 24
$-0.50
$-0.22
Q1 24
$-0.51
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SIBN
SIBN
Cash + ST InvestmentsLiquidity on hand
$286.5M
$42.2M
Total DebtLower is stronger
$51.6M
$35.6M
Stockholders' EquityBook value
$365.9M
$177.5M
Total Assets
$508.1M
$238.6M
Debt / EquityLower = less leverage
0.14×
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SIBN
SIBN
Q4 25
$286.5M
$42.2M
Q3 25
$294.3M
$26.5M
Q2 25
$302.7M
$34.1M
Q1 25
$316.2M
$41.2M
Q4 24
$333.7M
$34.9M
Q3 24
$196.8M
$30.2M
Q2 24
$214.1M
$25.6M
Q1 24
$225.6M
$32.0M
Total Debt
PRCT
PRCT
SIBN
SIBN
Q4 25
$51.6M
$35.6M
Q3 25
$51.6M
$35.5M
Q2 25
$51.5M
$35.5M
Q1 25
$51.5M
$35.5M
Q4 24
$51.5M
$35.5M
Q3 24
$51.4M
$36.2M
Q2 24
$51.4M
$36.1M
Q1 24
$51.4M
$36.1M
Stockholders' Equity
PRCT
PRCT
SIBN
SIBN
Q4 25
$365.9M
$177.5M
Q3 25
$380.3M
$172.1M
Q2 25
$385.8M
$170.3M
Q1 25
$389.2M
$167.3M
Q4 24
$402.2M
$167.0M
Q3 24
$241.2M
$165.0M
Q2 24
$251.8M
$164.7M
Q1 24
$264.0M
$165.5M
Total Assets
PRCT
PRCT
SIBN
SIBN
Q4 25
$508.1M
$238.6M
Q3 25
$511.5M
$234.3M
Q2 25
$513.1M
$230.9M
Q1 25
$519.4M
$227.3M
Q4 24
$534.0M
$230.4M
Q3 24
$374.1M
$227.0M
Q2 24
$374.4M
$223.8M
Q1 24
$382.9M
$223.7M
Debt / Equity
PRCT
PRCT
SIBN
SIBN
Q4 25
0.14×
0.20×
Q3 25
0.14×
0.21×
Q2 25
0.13×
0.21×
Q1 25
0.13×
0.21×
Q4 24
0.13×
0.21×
Q3 24
0.21×
0.22×
Q2 24
0.20×
0.22×
Q1 24
0.19×
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
SIBN
SIBN
Operating Cash FlowLast quarter
$-10.3M
$1.7M
Free Cash FlowOCF − Capex
$-12.2M
$440.0K
FCF MarginFCF / Revenue
-15.9%
0.8%
Capex IntensityCapex / Revenue
2.4%
2.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-58.3M
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
SIBN
SIBN
Q4 25
$-10.3M
$1.7M
Q3 25
$-6.6M
$2.3M
Q2 25
$-15.0M
$173.0K
Q1 25
$-17.0M
$-4.9M
Q4 24
$-32.4M
$1.2M
Q3 24
$-18.8M
$302.0K
Q2 24
$-15.7M
$-6.3M
Q1 24
$-32.3M
$-7.6M
Free Cash Flow
PRCT
PRCT
SIBN
SIBN
Q4 25
$-12.2M
$440.0K
Q3 25
$-9.5M
$-620.0K
Q2 25
$-17.8M
$-1.9M
Q1 25
$-18.8M
$-7.0M
Q4 24
$-33.6M
$-1.1M
Q3 24
$-19.0M
$-2.7M
Q2 24
$-16.8M
$-9.4M
Q1 24
$-34.2M
$-9.7M
FCF Margin
PRCT
PRCT
SIBN
SIBN
Q4 25
-15.9%
0.8%
Q3 25
-11.4%
-1.3%
Q2 25
-22.5%
-4.0%
Q1 25
-27.2%
-14.8%
Q4 24
-49.2%
-2.2%
Q3 24
-32.6%
-6.8%
Q2 24
-31.4%
-23.6%
Q1 24
-76.9%
-25.5%
Capex Intensity
PRCT
PRCT
SIBN
SIBN
Q4 25
2.4%
2.3%
Q3 25
3.4%
6.1%
Q2 25
3.5%
4.3%
Q1 25
2.7%
4.4%
Q4 24
1.7%
4.6%
Q3 24
0.4%
7.5%
Q2 24
2.0%
7.8%
Q1 24
4.4%
5.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

SIBN
SIBN

US$53.5M95%
Non Us$2.9M5%

Related Comparisons